Tweet
<img alt="" height="1" width="1" />
Medicare to Pay for Infusing Provenge
MedPage Today
The Medicare and Medicaid programs will pay physician practices for the cost of infusing the prostate cancer vaccine sipuleucel-T (Provenge) as well as reimbursing for the drug itself, drugmaker Dendreon ...
Medicare to Cover Infusion for Dendreon's ProvengeWall Street Journal
Medicare to cover Provenge infusion costs: DendreonReuters
Dendreon: Medicare will cover more Provenge costsBusinessWeek
FiercePharma -Beacon Equity Research -LocalizedUSA
all 57 news articles »
More...